Page 1 of Clinical Trials for Drug Exelon rivastigmine, 68 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Not yet recruiting
Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia
Last Updated: April 24, 2012
Condition(s): Alzheimer's Dementia
2
Not yet recruiting
Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors
Last Updated: March 5, 2012
Condition(s): Alzheimer's Disease
3
Completed
Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)
Last Updated: October 19, 2011
Condition(s): Parkinson's Disease Dementia
4
Recruiting
Mild Cognitive Impairment in Parkinson's Disease
Last Updated: January 23, 2012
Condition(s): Parkinson's Disease; Mild Cognitive Impairment
5
Completed
Rivastigmine For Methamphetamine Dependent Individuals
Last Updated: September 3, 2009
Condition(s): Substance-Related Disorders
6
Recruiting
A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease
Last Updated: April 24, 2012
Condition(s): Alzheimer's Disease
7
Recruiting
Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study
Last Updated: April 2, 2012
Condition(s): Neurocognitive Disturbance; HIV Infection
8
Active, not recruiting
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type
Last Updated: November 22, 2011
Condition(s): Alzheimer's Disease
9
Completed
Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients
Last Updated: March 19, 2012
Condition(s): Alzheimer Disease
10
Completed
Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)
Last Updated: December 8, 2005
Condition(s): Alzheimer Disease; Cognition Disorders
11
Enrolling by invitation
A 24 Week Open-Label Extension to Study CENA713DUS44
Last Updated: November 22, 2011
Condition(s): Alzheimer's Disease
12
Recruiting
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
Last Updated: February 20, 2012
Condition(s): Cocaine Dependence; Cocaine Addiction; Cocaine Abuse; Substance Abuse
13
Completed
Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
Last Updated: September 27, 2011
Condition(s): Alzheimer's Disease
14
Terminated
Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment
Last Updated: March 8, 2012
Condition(s): Multiple Sclerosis; Cognitive Impairment
15
Completed
Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease
Last Updated: May 27, 2011
Condition(s): Alzheimer's Disease
16
Completed
A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease
Last Updated: May 15, 2012
Condition(s): Alzheimer's Disease
17
Completed
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease
Last Updated: April 18, 2012
Condition(s): Alzheimer's Disease; Central Nervous System Diseases
18
Completed
An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits
Last Updated: November 16, 2011
Condition(s): Traumatic Brain Injury With Persistent Cognitive Deficits
19
Completed
Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia
Last Updated: November 16, 2011
Condition(s): Vascular Dementia
20
Completed
Rivastigmine as a Treatment for Methamphetamine Dependence
Last Updated: February 20, 2012
Condition(s): Methamphetamine Dependence; Substance Abuse; Methamphetamine Abuse

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Exelon+rivastigmine

Page 1 of Clinical Trials for Drug Exelon rivastigmine, 68 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About